Records containing: Paraganglioma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
CLINICAL_TRIALS study record update · 2026-04-23
A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2026-04-14
Single-arm Open-label Phase I/II Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
CLINICAL_TRIALS study record update · 2026-04-13
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
CLINICAL_TRIALS study record update · 2026-04-07
Validation and Extension Study of the Predictive Model for Intraoperative Hemodynamic Instability in Pheochromocytoma/Paraganglioma Resection - a Single-center, Prospective, Observational Cohort Study
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-03-17
Phase I Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors
CLINICAL_TRIALS study record update · 2026-03-02
Exploratory Phase II Study of LAnreotide in Metastatic Pheochromocytoma/PARAganglioma (LAMPARA)
CLINICAL_TRIALS study record update · 2026-03-02
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2026-02-27
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Patients With Pheochromocytoma and Paraganglioma
CLINICAL_TRIALS study record update · 2026-02-06
Clinical Application of New Pheochromocytoma Markers: INSERM Pilot Study of the Specificity of Elevated Plasma EM66 Concentrations in Patients With Pheochromocytoma or Paraganglioma Compared to Patients With Essential Hypertension
CLINICAL_TRIALS study record update · 2026-01-30
A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2026-01-14
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
CLINICAL_TRIALS study record update · 2025-11-21
68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.
CLINICAL_TRIALS study record update · 2025-11-18
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 2 Talazoparib and Temozolomide
CLINICAL_TRIALS study record update · 2025-10-15
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
CLINICAL_TRIALS study record update · 2025-09-26
the Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for the Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2025-07-20
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure Across a Diverse Health System
CLINICAL_TRIALS study record update · 2025-06-30
Prognostic's Factors of Head and Neck Paragangliomas Evolution
CLINICAL_TRIALS study record update · 2025-06-19
Exploratory Basket Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. CABATEN Study
CLINICAL_TRIALS study record update · 2025-06-13
Evaluation of the Safety and Sensitivity of 68Ga-DOTATOC PET/CT for Imaging NET Patients
CLINICAL_TRIALS study record update · 2025-06-12
A Pilot Study for Randomized Controlled Trial on the Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
CLINICAL_TRIALS study record update · 2025-01-21
A Prospective Study Assessing the Relationship Between Expression of the Norepinephrine Transporter and 18F-mFBG PET Imaging Results in Neuroblastoma Tumor, Other Neural Crest Tumors, and Organs Innervated by the Sympathetic Nervous System
CLINICAL_TRIALS study record update · 2024-11-27
A Multicenter Open-label Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors, Pheochromocytoma and Paragangliomas (PPGL)
CLINICAL_TRIALS study record update · 2024-11-21
HEPHESTOS - Hereditary Pheochromocytoma Assessment of Tumour Immunologies
CLINICAL_TRIALS study record update · 2024-11-01
Semiquantitative 131I-MIBG Scintigraphy Predicts Intraoperative Blood Pressure Fluctuation in Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma